Our Services
Medical Information
Helpful Resources
Published on: 9/12/2026
Magnesium citrate can be dangerous if you have kidney disease or certain heart conditions, because damaged kidneys may not clear excess magnesium, allowing it to build up to toxic levels (hypermagnesemia) that can cause nausea, flushing, muscle weakness, dangerously low blood pressure, slowed breathing, irregular heart rhythms, or heart block. Risk rises with higher doses, repeated use as a laxative or bowel prep, dehydration, older age, and medications such as diuretics, ACE inhibitors, or other magnesium and potassium supplements. Several important factors determine how cautious you should be, including your eGFR or CKD stage, whether you have an existing arrhythmia or conduction problem, and warning symptoms that signal an emergency; see below to understand more before taking or continuing it.
Because magnesium toxicity can look like ordinary fatigue or stomach upset in its early stages, it is easy to dismiss symptoms that actually warrant urgent evaluation. If you have kidney or heart concerns and are noticing weakness, a slow or fluttering heartbeat, confusion, or shortness of breath, take a free, instant, online symptom check to better understand what may be going on and to get clear guidance on your next steps.
Last reviewed for medical accuracy: 09/12/2026
Magnesium citrate is a common over-the-counter supplement and laxative. While it can help relieve occasional constipation and boost magnesium levels, it isn’t risk-free—especially if you have kidney disease or heart conditions. Below, we explain how magnesium citrate works, why kidney and heart health matter, the possible dangers, and what you can do to stay safe.
Magnesium citrate is a combination of magnesium (an essential mineral) and citric acid. It’s available in:
Key uses include:
Magnesium levels in your blood are tightly regulated:
If kidneys don’t work well, excess magnesium can build up, leading to potentially serious effects on muscles, nerves and the heart.
When kidneys are damaged or not filtering efficiently, they can’t remove extra magnesium fast enough. This puts you at risk for hypermagnesemia (high blood magnesium levels), which can cause:
People with chronic kidney disease (CKD) or acute kidney injury (AKI) should be cautious with any magnesium-based products, including magnesium citrate. Even normal doses may raise magnesium levels too much if kidney function is impaired.
Magnesium plays a direct role in heart function:
Too much magnesium can slow heart rate or cause dangerous heart rhythms. In people with existing heart disease—such as heart failure, arrhythmias, or those on certain heart medications—magnesium citrate could worsen:
Watch for early signs of hypermagnesemia. If you have kidney or heart issues, these symptoms warrant prompt medical advice:
In severe cases, breathing can slow or stop. If you experience any concerning symptoms after taking magnesium citrate, stop the supplement and seek medical attention.
Consider avoiding or lowering the dose of magnesium citrate if you have any of the following:
Always review all your medications and health conditions with a healthcare provider before starting magnesium citrate.
If your healthcare provider gives the green light to use magnesium citrate, follow these safety tips:
Even if you follow the guidelines, certain signs mean it’s time to get medical help right away:
For non-urgent concerns or to explore your symptoms safely at home, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
If magnesium citrate isn’t right for you, talk to your doctor about alternatives:
This information is intended to help you understand the risks of magnesium citrate when you have kidney or heart issues. It does not replace professional medical advice. Always speak to a doctor before starting or stopping any supplement—especially if you have potentially life-threatening conditions. If you experience any serious or unusual symptoms, seek medical attention immediately.
(References)
* Golzarian J, Scott HW Jr, Richards WO. Hypermagnesemia-induced paralytic ileus. Dig Dis Sci. 1994 May;39(5):1138-42. doi: 10.1007/BF02087570. PMID: 8174429.
* Drach GW. Renal calculi. Curr Opin Urol. 1999 Mar;9(2):101-5. doi: 10.1097/00042307-199903000-00002. PMID: 10726078.
* Lim YJ, Hong SJ. What is the best strategy for successful bowel preparation under special conditions? World J Gastroenterol. 2014 Mar 21;20(11):2741-5. doi: 10.3748/wjg.v20.i11.2741. PMID: 24659865; PMCID: PMC3961988.
* Mathus-Vliegen EMH, van der Vliet K, Wignand-van der Storm IJ, Stadwijk JS. Efficacy and Safety of Sodium Picosulfate/Magnesium Citrate for Bowel Preparation in a Physically Disabled Outpatient Population: A Randomized, Endoscopist-Blinded Comparison With Ascorbic Acid-Enriched Polyethylene Glycol Solution Plus Bisacodyl (The PICO-MOVI Study). Dis Colon Rectum. 2018 Feb;61(2):239-249. doi: 10.1097/DCR.0000000000000956. PMID: 29337780.
* Yao Z, Xu Y, Ma W, Sun XY, Jia S, Zheng Y, Liu X, Fan Y, Wang C. Magnesium Citrate Protects Against Vascular Calcification in an Adenine-induced Chronic Renal Failure Rat Model. J Cardiovasc Pharmacol. 2018 Dec;72(6):270-276. doi: 10.1097/FJC.0000000000000590. PMID: 29738375.
* Hubbard G, Nerad R, Wojtasik L. Hypermagnesaemia causing mesenteric ischaemia and small bowel infarction. BMJ Case Rep. 2021 Jun 22;14(6). doi: 10.1136/bcr-2021-241928. Epub 2021 Jun 22. PMID: 34158327; PMCID: PMC8220516.
* Awan A, Basulaiman B, Stober C, Clemons M, Fergusson D, Hilton J, Al Ghareeb W, Goodwin R, Ibrahim M, Hutton B, Vandermeer L, Mallick R, Vickers MM. Oral magnesium supplements for cancer treatment-induced hypomagnesemia: Results from a pilot randomized trial. Health Sci Rep. 2021 Dec;4(4):e443. doi: 10.1002/hsr2.443. Epub 2021 Dec 14. PMID: 34938893; PMCID: PMC8669698.
* Vermeulen EA, Eelderink C, Hoekstra T, van Ballegooijen AJ, Raijmakers P, Beulens JW, de Borst MH, Vervloet MG. Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease. Trials. 2022 Sep 12;23(1):769. doi: 10.1186/s13063-022-06562-9. Epub 2022 Sep 12. PMID: 36096824; PMCID: PMC9465140.
* Storz MA, Ronco AL. Citrate-based dietary alkali supplements available in Germany: an overview. J Pharm Health Care Sci. 2024 May 10;10(1):22. doi: 10.1186/s40780-024-00342-0. Epub 2024 May 10. PMID: 38730472; PMCID: PMC11084099.
* Rodriguez-Hesles CA, Alkhatatbeh H, Alonso Bartolomé MB, Valladares Ferreiro CA, Ayllón Blanco HR, Calzas Montalvo C, Carrasco Gómez D, Casadevall Rubau M, Casas Martinez EM, Esturo Sacristan S, Gómez Garberí M, Gómez-Jordana Mañas B, Gras Martinez RM, Morales Martínez A, Hernandez-Peñalver P, Juste Alvarez S, López Sierra A, Mas Lucas RM, Mohedano Sánchez I, Montuenga Fernandez I, Nakdali Kassab B, Negueroles-Garcia M, Ruibal Gago L, Sánchez L, Isern B, Trinchieri A. Urine alkalinization for dissolution of uric acid stones and treatment of other urological diseases with a treatment combining potassium magnesium citrate and theobromine. Arch Ital Urol Androl. 2025 Mar 28;97(1):13824. doi: 10.4081/aiua.2025.13824. Epub 2025 Mar 28. PMID: 40162813.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.